When: April 18, 2026
12:00 – 4:00 pm ET
This new one-day live course features expert presentations and interactive discussions on current advancements and emerging trends in addiction. The course includes six focused topics.
Before the live session, participants will receive access to a 90-minute on-demand video. In this video portion, faculty provide the theoretical framework for each psychotherapy modality and demonstrate techniques through simulated patient sessions.
The live program will allow participants to engage directly with expert presenters, ask questions, and explore key topics in greater depth.
Join us to expand your knowledge, connect with experts, and strengthen your skills in addiction psychiatry.
Member | Non-Member | Trainees | |
| Early Bird Rate Early Bird Rate ends on March 23, 2026 | $200 | $225 | $75 |
| Standard Rate | $225 | $250 | $100 |
Trainees must email [email protected] for discount code. If you are not a AAAP member, trainees Join for FREE.
Refund policy:
A 100% refund will be honored for cancellations requested in writing within 48 hours of purchase. No refunds will be honored after 48 hours of purchase. All refund requests must be submitted in writing to [email protected].
This course is intended for psychiatrists, psychologists, social workers, nurse practitioners, physician assistants, and addiction counselors who are working with individuals with substance use disorders.
Learners who attend this activity will receive an in-depth educational experience in six psychotherapy modalities. After participating in this course, learners should be able to:
- Understand the theoretical framework for each psychotherapy approach presented in the 90-minute video modules.
- Recognize how each modality is applied in practice through faculty demonstrations with simulated patients.
- Engage in real-time discussion during the 30-minute live sessions and use faculty feedback to deepen their understanding of the techniques.
- Motivational Enhancement Therapy
- Cognitive-Behavioral Therapy/Relapse Prevention Therapy (CBT-RPT)
- Acceptance and Commitment Therapy (ACT)
- 12-Step Facilitation Therapy (TSF)
- Contingency Management (CM)
- Community Reinforcement and Family Training (CRAFT)
Saturday, April 18, 2026 Presenter Time: 30 minutes each / Breaks: 10 minutes between sessions | ||
| 12:00 PM-12:05 PM | Welcome and Introduction to the Live Session John Mariani, MD, and Kevin Sevarino, MD, PhD | |
| 12:05 PM–12:35 PM | Motivational Enhancement Therapy Brian Hurley, MD | |
| 12:35 PM–12:45 PM | Break | |
| 12:45 PM–1:15 PM | Cognitive-Behavioral Therapy/Relapse Prevention Therapy (CBT-RPT) Brian Kiluk, PhD | |
| 1:15 PM–1:25 PM | Break | |
| 1:25 PM–1:55 PM | Acceptance and Commitment Therapy (ACT) Josh King, PsyD | |
| 1:55 PM–2:05 PM | Break | |
| 2:05 PM–2:35 PM | 12-Step Facilitation Therapy (TSF) John Mariani, MD | |
| 2:35 PM–2:45 PM | Break | |
| 2:45 PM–3:15 PM | Contingency Management (CM) Christopher Blazes, MD | |
| 3:15 PM–3:25 PM | Break | |
| 3:25 PM–3:55 PM | Community Reinforcement and Family Training (CRAFT) Ken Carpenter, PhD | |
| 3:55 PM–4:00 PM | End of the Day Wrap-Up | |
Presenters
Dr. Blazes is Associate Professor of Psychiatry at OHSU. He is triple board-certified in psychiatry, addiction psychiatry, and emergency medicine and is the director of the OHSU addiction psychiatry Fellowship. Dr Blazes is a clinician educator whose practice is based out of the Portland VA Medical Center. He lectures widely and publishes on such topics as benzodiazepines, buprenorphine, and the neurobiology of addiction and recovery. He also created the AAAP Advanced Addiction Psychotherapy Curriculum which offers monthly live seminars as well as archived content on multiple psychotherapeutic modalities.
Kenneth M. Carpenter, PhD is a clinical psychologist with over 25 years of experience developing, implementing, and evaluating evidence-based strategies for helping individuals make essential lifestyle changes. He has received federal and private foundation grant money for investigating the psychological, behavioral, and neurobiological factors associated with substance use and its treatment. He holds an academic appointment in Columbia University’s Department of Psychiatry and is a Research Scientist in the Division on Substance Use Disorders at the New York State Psychiatric Institute. For the past 13 years, he and his colleagues at CMC:Foundation for Change have been providing community-based training for families and professionals in the use of unilateral helping models to cultivate interpersonal contexts that invite and support change.
Brian Hurley, MD, MBA, DFASAM, FAPA is an addiction physician and the Medical Director of the Bureau of Substance Abuse Prevention and Control in the Los Angeles County Department of Public Health and a volunteer assistant clinical professor of addiction medicine in the UCLA Department of Family Medicine. He is the Immediate Past President of the American Society of Addiction Medicine. He is a Primary Investigator for the Centers for Disease Control Overdose to Action:LOCAL award to Los Angeles County. He is a member of the Motivational Interviewing Network of Trainers.
Dr. Brian Kiluk is Associate Professor of Psychiatry at Yale School of Medicine and Director of the Yale Psychotherapy Development Center conducting research that aims to improve treatments for substance use and addiction. He earned a Ph.D. in Clinical Psychology in 2009 from the University of Maryland, Baltimore County, followed by postdoctoral training in addictions treatment research at Yale, where he has remained for the past 15 years. His primary area of research focuses on the development, enhancement, and dissemination of evidence-based treatments for substance use disorders, specifically Cognitive Behavioral Therapy (CBT), and includes the evaluation of a novel digital version of CBT known as CBT4CBT. He has led efforts to expand access to CBT for substance use disorders through digital therapeutics, as well as the identification of factors that moderate its effectiveness and the mechanisms that promote behavior change. His work has been consistently funded through research grants from the National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, serving as Principal Investigator on multiple projects, with total funding over $13 million. He has published over 100 peer-reviewed journal articles and book chapters and been an invited speaker at national and international conferences. Dr. Kiluk also holds leadership roles within the Yale Department of Psychiatry as co-Director of an NIH-funded T32 Postdoctoral Fellowship, and as Director of Evidence-based Research and Training for the Yale Doctoral Internship, providing support and mentorship to the next generation of clinician-scientists. Lastly, as a nationally recognized expert in CBT, Dr. Kiluk consults with treatment facilities across the US to provide workshop training, as well as ongoing fidelity monitoring and coaching in the delivery of CBT.
Dr. King is a licensed psychologist with a Doctorate in Clinical and School Psychology from the Ferkauf Graduate School of Psychology at Yeshiva University. Dr. King hosted the Beyond Addiction Show, a weekly podcast dedicated to disseminating information about evidence-based treatments and interviewing people who have worked to move the conversation about substance use forward. Dr. King currently oversees the Day Program, CMC’s intensive outpatient treatment program. He is an Invitation to Change Trainer and has trained throughout the United States and in Uganda. He is a specialist in Dialectical Behavior Therapy (DBT), Cognitive Behavioral Treatment for Insomnia (CBT-I) and Acceptance and Commitment Therapy (ACT). He co-authored a chapter in Different Patients, Different Therapies (Cabaniss & Holoshitz, 2019) on using ACT to work with substance use disorders.
John J. Mariani, MD is an Associate Professor of Clinical Psychiatry at the Columbia University Vagelos College of Physicians and Surgeons and a Research Psychiatrist at the New York State Psychiatric Institute (NYSPI). Dr. Mariani is the Director of the Substance Treatment and Research Service (STARS) in the Division on Substance Use Disorders at the NYSPI/Columbia University Irving Medical Center. Dr. Mariani attended the New York University School of Medicine, completed a psychiatry residency at the Beth Israel Medical Center/Albert Einstein College of Medicine, and an addiction psychiatry clinical and research fellowship at Columbia University Medical Center and the New York State Psychiatric Institute. He serves on the board of the American Academy of Addiction Psychiatry and is the medical advisor to the Major League Baseball Players Association. Dr. Mariani’s research is focused on the development of novel medication treatments for substance use disorders and related co-occurring psychiatric disorders. He has received grant funding from the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), as well as private foundations. Dr. Mariani has over 50 peer-reviewed scientific publications, in addition to a dozen book chapters on the treatment of substance use disorders.